Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
specificThe reemergence of transformed B-cell non-Hodgkin lymphoma after a period of remission.
6
Centers
6
Active Trials
—
Cancer Funding
Top Centers for Recurrent Transformed B-Cell Non-Hodgkin Lymphoma(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 58.3 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 58.3 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 58.3 |
| 4 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 58.3 |
| 5 | University of Illinois Cancer CenterChicago, IL Active Research Program | 58.3 |
| 6 | Cancer Center at IllinoisUrbana, IL Active Research Program | 58.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →